Summit Therapeutics Currently Down Seven Days Straight, On Pace for Longest Losing Streak Since February 2023 -- Data Talk

Dow Jones
11/21

Summit Therapeutics Inc. ( SMMT ) is currently at $16.12, down $0.44 or 2.66%

 

--Would be lowest close since Sept. 6, 2024, when it closed at $12.27

--On pace for largest percent decrease since Nov. 17, 2025, when it fell 5.99%

--Currently down seven consecutive days; down 15.87% over this period

--Longest losing streak since Feb. 13, 2023, when it fell for seven straight trading days

--Worst seven day stretch since the seven days ending Oct. 22, 2025, when it fell 16.44%

--Down 14.75% month-to-date

--Down 9.67% year-to-date; on pace for worst year since 2023, when it fell 38.59%

--Down 56.08% from its all-time closing high of $36.70 on April 24, 2025

--Down 12.49% from 52 weeks ago (Nov. 21, 2024), when it closed at $18.42

--Down 56.08% from its 52-week closing high of $36.70 on April 24, 2025

--Would be a new 52-week closing low

--Traded as low as $15.88; lowest intraday level since April 9, 2025, when it hit $15.78

--Down 4.11% at today's intraday low

 

All data as of 2:34:38 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 20, 2025 14:38 ET (19:38 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10